Found 1503 results
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
E. D. Cram, Rockey, D. D., and Dolan, B. P., Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011., BMC Microbiol, vol. 17, no. 1, p. 98, 2017.
J. P. Bannantine, Stamm, W. E., Suchland, R. J., and Rockey, D. D., Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates., Infection and immunity, vol. 66, no. 12, pp. 6017-21, 1998.
J. P. Bannantine, Stamm, W. E., Suchland, R. J., and Rockey, D. D., Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates., Infect Immun, vol. 66, no. 12, pp. 6017-21, 1998.
T. Hackstadt, Rockey, D. D., Heinzen, R. A., and Scidmore, M. A., Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane., The EMBO journal, vol. 15, no. 5, pp. 964-77, 1996.
T. Hackstadt, Rockey, D. D., Heinzen, R. A., and Scidmore, M. A., Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane., EMBO J, vol. 15, no. 5, pp. 964-77, 1996.
M. Xia, Suchland, R. J., Bumgarner, R. E., Peng, T., Rockey, D. D., and Stamm, W. E., Chlamydia trachomatis variant with nonfusing inclusions: growth dynamic and host-cell transcriptional response., The Journal of infectious diseases, vol. 192, no. 7, pp. 1229-36, 2005.
M. Xia, Suchland, R. J., Bumgarner, R. E., Peng, T., Rockey, D. D., and Stamm, W. E., Chlamydia trachomatis variant with nonfusing inclusions: growth dynamic and host-cell transcriptional response., J Infect Dis, vol. 192, no. 7, pp. 1229-36, 2005.
D. D. Rockey, Wang, J., Lei, L., and Zhong, G., Chlamydia vaccine candidates and tools for chlamydial antigen discovery., Expert review of vaccines, vol. 8, no. 10, pp. 1365-77, 2009.
D. D. Rockey, Wang, J., Lei, L., and Zhong, G., Chlamydia vaccine candidates and tools for chlamydial antigen discovery., Expert Rev Vaccines, vol. 8, no. 10, pp. 1365-77, 2009.
N. Borel, Leonard, C., Slade, J., and Schoborg, R. V., Chlamydial Antibiotic Resistance and Treatment Failure in Veterinary and Human Medicine., Curr Clin Microbiol Rep, vol. 3, pp. 10-18, 2016.
W. J. Brown, Skeiky, Y. A. W., Probst, P., and Rockey, D. D., Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol., Infection and immunity, vol. 70, no. 10, pp. 5860-4, 2002.
W. J. Brown, Skeiky, Y. A. W., Probst, P., and Rockey, D. D., Chlamydial antigens colocalize within IncA-laden fibers extending from the inclusion membrane into the host cytosol., Infect Immun, vol. 70, no. 10, pp. 5860-4, 2002.
D. Alzhanov, Barnes, J., Hruby, D. E., and Rockey, D. D., Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA., BMC microbiology, vol. 4, p. 24, 2004.
D. Alzhanov, Barnes, J., Hruby, D. E., and Rockey, D. D., Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incA., BMC Microbiol, vol. 4, p. 24, 2004.
A. W. Biondo and de Morais, H. Autran, Chloride: a quick reference., The Veterinary clinics of North America. Small animal practice, vol. 38, no. 3, pp. 459-65, viii, 2008.
Y. Vengrenyuk, Nishi, H., Long, X., Ouimet, M., Savji, N., Martinez, F. O., Cassella, C. P., Moore, K. J., Ramsey, S. A., Miano, J. M., and Fisher, E. A., Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype., Arterioscler Thromb Vasc Biol, vol. 35, no. 3, pp. 535-46, 2015.
R. J. Suchland, Carrell, S. J., Wang, Y., Hybiske, K., Kim, D. B., Dimond, Z. E., P Hefty, S., and Rockey, D. D., Chromosomal Recombination Targets in Interspecies Lateral Gene Transfer., J Bacteriol, vol. 201, no. 23, 2019.
L. L. Blythe, Schmitz, J. A., Roelke, M., and Skinner, S., Chronic encephalomyelitis caused by canine distemper virus in a Bengal tiger., Journal of the American Veterinary Medical Association, vol. 183, no. 11, pp. 1159-62, 1983.
L. L. Blythe and Craig, A. M., A chronic in vivo liver perfusion technique in ruminants., Veterinary and human toxicology, vol. 28, no. 3, pp. 201-4, 1986.
K. M. Lebold, Löhr, C. V., Barton, C. L., Miller, G. W., Labut, E. M., Tanguay, R. L., and Traber, M. G., Chronic vitamin E deficiency promotes vitamin C deficiency in zebrafish leading to degenerative myopathy and impaired swimming behavior., Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, vol. 157, no. 4, pp. 382-9, 2013.
P. Bebas, Goodall, C. P., Majewska, M., Neumann, A., Giebultowicz, J. M., and Chappell, P. E., Circadian clock and output genes are rhythmically expressed in extratesticular ducts and accessory organs of mice., The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol. 23, no. 2, pp. 523-33, 2009.
J. D. Alvarez, Hansen, A., Ord, T., Bebas, P., Chappell, P. E., Giebultowicz, J. M., Williams, C., Moss, S., and Sehgal, A., The circadian clock protein BMAL1 is necessary for fertility and proper testosterone production in mice., Journal of biological rhythms, vol. 23, no. 1, pp. 26-36, 2008.
P. E. Chappell, White, R. S., and Mellon, P. L., Circadian gene expression regulates pulsatile gonadotropin-releasing hormone (GnRH) secretory patterns in the hypothalamic GnRH-secreting GT1-7 cell line., The Journal of neuroscience : the official journal of the Society for Neuroscience, vol. 23, no. 35, pp. 11202-13, 2003.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S., Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice., Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice., The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.

Pages